You searched for lawsuit - Page 11 of 23

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute

December 7, 2019 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the […]

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute Read More »

Bad Batch podcast’s dark picture of perinatal stem cell industry

November 20, 2019 / Professor Paul Knoepfler, Ph.D. / 4 Comments

I finished listening to the first 6 episodes of the Bad Batch podcast last week. The series is by medical journalist Laura Beil. I think there will be a 7th episode that’s a Q&A. I highly recommend listening to the series even if parts are wrenching at times like how much patients and families have

Bad Batch podcast’s dark picture of perinatal stem cell industry Read More »

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope

September 12, 2019 / Professor Paul Knoepfler, Ph.D. / 6 Comments

A new right-to-try company called Beacon of Hope is stirring some intense discussion. State and federal right-to-try laws could potentially change the fabric of how many investigational studies are conducted. That may happen through firms like Beacon of Hope. However, we don’t know much about the firm. I’m hoping to help change that. Today’s post

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope Read More »

StemGenex clinic bankruptcy reveals surprises including huge revenue

September 11, 2019 / Professor Paul Knoepfler, Ph.D. / 6 Comments

How much money and how many patients do stem cell clinics like San Diego’s StemGenex make each year? A new court document has some insights from an unexpected angle. I’ve been following StemGenex for years here on The Niche. It’s been a rollercoaster ride. Things hit a new low today, perhaps marking the operational end

StemGenex clinic bankruptcy reveals surprises including huge revenue Read More »

Kristin Comella resigns from embattled clinic firm US Stem Cell

September 8, 2019 / Professor Paul Knoepfler, Ph.D. / 8 Comments

US Stem Cell, Inc. reports in a new SEC filing that its key leader Kristin Comella has resigned as of September 1. I never thought I’d see the day when Kristin Comella and US Stem Cell, Inc. parted ways. To me Comella seemed like the driving force behind the company, which is now subject to

Kristin Comella resigns from embattled clinic firm US Stem Cell Read More »

‘Bottom of stem cell barrel’? Utah piece sparks legal threat

August 20, 2019 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Up until now Utah hasn’t immediately come to mind as a hub for stem cell issues, but things are heating up there in 2019. Utah? I was going to do a blog post here on The Niche last month about perinatal (birth-related) biologics and stem cell-related supply companies in Utah. Some of their customers appear

‘Bottom of stem cell barrel’? Utah piece sparks legal threat Read More »

US Senate bill would ban embryonic stem cell research

July 31, 2019 / Professor Paul Knoepfler, Ph.D. / 13 Comments

embryonic-stem-cell-research-funding-ban

Here we go again with people trying to ban funding of embryonic stem cell research. Really? Yes, including according to a new article from the Catholic News Agency. Who is trying to get this ban? Some Republicans in The U.S. Senate. I’ve wondered for years if the Trump Administration might take action against embryonic stem

US Senate bill would ban embryonic stem cell research Read More »

Congress pushes FDA on stem cell clinic mess in new letter

July 28, 2019 / Professor Paul Knoepfler, Ph.D. / Leave a Comment

Congress-letter-to-FDA-stem-cell-clinics-2019

It can be kind of a big deal when politicians, especially at the federal level, write the FDA about stem cells. Is this going to be good news or bad? Some combination? I tend to worry that some senators or representatives might pressure the FDA to weaken oversight. However, lately it seems like the opposite

Congress pushes FDA on stem cell clinic mess in new letter Read More »

A new way patients may get money back from stem cell clinics

July 23, 2019 / Professor Paul Knoepfler, Ph.D. / 21 Comments

Let’s face it, there are loads of stem cell clinics looking for patients/customers. I think most are taking advantage of patients and some of these are just rotten. Admittedly there are hundreds of clinics that aren’t that bad. They also might be FDA compliant. However, they still are selling stem cells that aren’t really proven

A new way patients may get money back from stem cell clinics Read More »

Can clinic biz US Stem reboot after losing suit? Its email to customers & more

July 2, 2019 / Professor Paul Knoepfler, Ph.D. / 2 Comments

The unproven stem cell clinic firm US Stem Cell Inc. is in a world of hurt. If a federal judge says you can no longer sell your key commercial offering, how do you survive as a company? US Stem probably has been thinking about that possibility for months. Still, it’s not yet clear where the

Can clinic biz US Stem reboot after losing suit? Its email to customers & more Read More »

Search Results for: lawsuit